{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:49:52Z","timestamp":1784728192394,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00109-009-0441-8","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T00:04:48Z","timestamp":1233014688000},"page":"423-433","source":"Crossref","is-referenced-by-count":27,"title":["Ethyl pyruvate improves survival in awake hemorrhage"],"prefix":"10.1007","volume":"87","author":[{"given":"Bolin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin A.","family":"Deitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"441_CR1","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","volume":"356","author":"PM Mannucci","year":"2007","unstructured":"Mannucci PM, Levi M (2007) Prevention and treatment of major blood loss. N Engl J Med 356:2301\u20132311","journal-title":"N Engl J Med"},{"key":"441_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31816757f7","volume":"247","author":"GD Rushing","year":"2008","unstructured":"Rushing GD, Britt LD (2008) Reperfusion injury after hemorrhage: a collective review. Ann Surg 247:929\u2013937","journal-title":"Ann Surg"},{"key":"441_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","volume":"11","author":"L Ulloa","year":"2005","unstructured":"Ulloa L, Tracey KJ (2005) The \u201ccytokine profile\u201d: a code for sepsis. Trends Mol Med 11:56\u201363","journal-title":"Trends Mol Med"},{"key":"441_CR4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1797","volume":"4","author":"L Ulloa","year":"2005","unstructured":"Ulloa L (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4:673\u2013684","journal-title":"Nat Rev Drug Discov"},{"key":"441_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.cb.09.110193.001533","volume":"9","author":"KJ Tracey","year":"1993","unstructured":"Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317\u2013343","journal-title":"Annu Rev Cell Biol"},{"key":"441_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","volume":"45","author":"KJ Tracey","year":"1994","unstructured":"Tracey KJ, Cerami A (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491\u2013503","journal-title":"Annu Rev Med"},{"key":"441_CR7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1213\/00000539-199905000-00005","volume":"88","author":"TJ Gan","year":"1999","unstructured":"Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG (1999) Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 88:992\u2013998","journal-title":"Anesth Analg"},{"key":"441_CR8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00003246-199709000-00026","volume":"25","author":"VG Nielsen","year":"1997","unstructured":"Nielsen VG, Tan S, Brix AE, Baird MS, Parks DA (1997) Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia\u2013reperfusion in rabbits. Crit Care Med 25:1565\u20131574","journal-title":"Crit Care Med"},{"key":"441_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00003246-200202000-00006","volume":"30","author":"JA Kellum","year":"2002","unstructured":"Kellum JA (2002) Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid\u2013base balance with Hextend compared with saline. Crit Care Med 30:300\u2013305","journal-title":"Crit Care Med"},{"key":"441_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.shk.0000156667.04628.1f","volume":"23","author":"MT Handrigan","year":"2005","unstructured":"Handrigan MT, Bentley TB, Oliver JD, Tabaku LS, Burge JR, Atkins JL (2005) Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats. Shock 23:337\u2013343","journal-title":"Shock"},{"key":"441_CR11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.TA.0000062968.69867.6F","volume":"55","author":"J Mapstone","year":"2003","unstructured":"Mapstone J, Roberts I, Evans P (2003) Fluid resuscitation strategies: a systematic review of animal trials. J Trauma 55:571\u2013589","journal-title":"J Trauma"},{"key":"441_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0003-4975(95)00570-B","volume":"60","author":"AR Cordell","year":"1995","unstructured":"Cordell AR (1995) Milestones in the development of cardioplegia. Ann Thorac Surg 60:793\u2013796","journal-title":"Ann Thorac Surg"},{"key":"441_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0300-9572(03)00209-0","volume":"58","author":"TF Baskett","year":"2003","unstructured":"Baskett TF (2003) The resuscitation greats: Sydney Ringer and lactated Ringer\u2019s solution. Resuscitation 58:5\u20137","journal-title":"Resuscitation"},{"key":"441_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9258(18)65256-1","volume":"221","author":"CM Montgomery","year":"1956","unstructured":"Montgomery CM, Fairhurst AS, Webb JL (1956) Metabolic studies on heart mitochondria. III. The action of parapyruvate on \u2212\u03b1-ketoglutaric oxidase. J Biol Chem 221:369\u2013376","journal-title":"J Biol Chem"},{"key":"441_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0300-9572(01)00325-2","volume":"50","author":"PN Slovin","year":"2001","unstructured":"Slovin PN, Huang CJ, Cade JR, Wood CE, Nasiroglu O, Privette M, Orbach P, Skimming JW (2001) Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock. Resuscitation 50:109\u2013115","journal-title":"Resuscitation"},{"key":"441_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0003-2697(64)90043-0","volume":"8","author":"RW Vonkorff","year":"1964","unstructured":"Vonkorff RW (1964) Pyruvate-C14, purity and stability. Anal Biochem 8:171\u2013178","journal-title":"Anal Biochem"},{"key":"441_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ACO.0b013e3282f63c2e","volume":"21","author":"MP Fink","year":"2008","unstructured":"Fink MP (2008) Ethyl pyruvate. Curr Opin Anaesthesiol 21:160\u2013167","journal-title":"Curr Opin Anaesthesiol"},{"key":"441_CR18","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1073\/pnas.192222999","volume":"99","author":"L Ulloa","year":"2002","unstructured":"Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 99:12351\u201312356","journal-title":"Proc Natl Acad Sci U S A"},{"key":"441_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1749-6632.2003.tb06075.x","volume":"987","author":"L Ulloa","year":"2003","unstructured":"Ulloa L, Fink MP, Tracey KJ (2003) Ethyl pyruvate protects against lethal systemic inflammation by preventing HMGB1 release. Ann NY Acad Sci 987:319\u2013321","journal-title":"Ann NY Acad Sci"},{"key":"441_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00024382-200206000-00006","volume":"17","author":"ZS Tawadrous","year":"2002","unstructured":"Tawadrous ZS, Delude RL, Fink MP (2002) Resuscitation from hemorrhagic shock with Ringer\u2019s ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17:473\u2013477","journal-title":"Shock"},{"key":"441_CR21","doi-asserted-by":"crossref","first-page":"G212","DOI":"10.1152\/ajpgi.00022.2002","volume":"283","author":"R Yang","year":"2002","unstructured":"Yang R, Gallo DJ, Baust JJ, Uchiyama T, Watkins SK, Delude RL, Fink MP (2002) Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283:G212\u2013G221","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"441_CR22","first-page":"248","volume":"23","author":"KE Mulier","year":"2005","unstructured":"Mulier KE, Beilman GJ, Conroy MJ, Taylor JH, Skarda DE, Hammer BE (2005) Ringer\u2019s ethyl pyruvate in hemorrhagic shock and resuscitation does not improve early hemodynamics or tissue energetics. Shock 23:248\u2013252","journal-title":"Shock"},{"key":"441_CR23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.bcp.2005.08.015","volume":"70","author":"PL Sappington","year":"2005","unstructured":"Sappington PL, Cruz RJ Jr., Harada T, Yang R, Han Y, Englert JA, Ajami AA, Killeen ME, Delude RL, Fink MP (2005) The ethyl pyruvate analogues, diethyl oxaloproprionate, 2-acetamidoacrylate, and methyl-2-acetamidoacrylate, exhibit anti-inflammatory properties in vivo and\/or in vitro. Biochem Pharmacol 70:1579\u20131592","journal-title":"Biochem Pharmacol"},{"key":"441_CR24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archsurg.142.2.166","volume":"142","author":"F Su","year":"2007","unstructured":"Su F, Wang Z, Cai Y, Remmelink M, Vincent JL (2007) Beneficial effects of ethyl pyruvate in septic shock from peritonitis. Arch Surg 142:166\u2013171","journal-title":"Arch Surg"},{"key":"441_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","volume":"9","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517\u2013524","journal-title":"Nat Med"},{"key":"441_CR26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/CCM.0B013E318164403B","volume":"36","author":"J Su","year":"2008","unstructured":"Su J, Li X, Cui X, Li Y, Fitz Y, Hsu L, Mani H, Quezado M, Eichacker PQ (2008) Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged mice. Crit Care Med 36:1059\u20131067","journal-title":"Crit Care Med"},{"key":"441_CR27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/CCM.0b013e31816a1414","volume":"36","author":"JJ Tenhunen","year":"2008","unstructured":"Tenhunen JJ (2008) Bull\u2019s eye missed by the magic bullet: preclinical investigations, publication bias, and promising new interventions. Crit Care Med 36:1361\u20131363","journal-title":"Crit Care Med"},{"key":"441_CR28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1034\/j.1399-3003.2000.16d22.x","volume":"16","author":"BT Peterson","year":"2000","unstructured":"Peterson BT, Miller EJ, Griffith DE, Rowjee R, McWaters P (2000) Modulation by pentobarbital of neutrophil responses to inhaled E. coli endotoxin in sheep: role of lung epithelium. Eur Respir J 16:697\u2013703","journal-title":"Eur Respir J"},{"key":"441_CR29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1189\/jlb.71.5.782","volume":"71","author":"J Wang","year":"2002","unstructured":"Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S (2002) The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol 71:782\u2013790","journal-title":"J Leukoc Biol"},{"key":"441_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00024382-200212000-00017","volume":"18","author":"LJ Giassi","year":"2002","unstructured":"Giassi LJ, Poynter AK, Gainer JL (2002) Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy. Shock 18:585\u2013588","journal-title":"Shock"},{"key":"441_CR31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00005373-198806000-00006","volume":"28","author":"CH Wu","year":"1988","unstructured":"Wu CH, Bogusky RT, Holcroft JW, Kramer GC (1988) NMR monitoring of phosphate metabolism of rat skeletal muscle during hemorrhage and resuscitation. J Trauma 28:757\u2013764","journal-title":"J Trauma"},{"key":"441_CR32","doi-asserted-by":"crossref","unstructured":"Cai B, Chen F, Lin X, Levente K, Miller EJ, Szabo C, Deitch E, Ulloa L (2009) Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. Crit Care Med (in press)","DOI":"10.1097\/CCM.0b013e31819b8237"},{"key":"441_CR33","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1074\/jbc.M701465200","volume":"282","author":"D Ditsworth","year":"2007","unstructured":"Ditsworth D, Zong WX, Thompson CB (2007) Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus. J Biol Chem 282:17845\u201317854","journal-title":"J Biol Chem"},{"key":"441_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00024382-199805000-00005","volume":"9","author":"C Szabo","year":"1998","unstructured":"Szabo C (1998) Potential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 9:341\u2013344","journal-title":"Shock"},{"key":"441_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","volume":"54","author":"L Virag","year":"2002","unstructured":"Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375\u2013429","journal-title":"Pharmacol Rev"},{"key":"441_CR36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421\u2013440","journal-title":"Nat Rev Drug Discov"},{"key":"441_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0196-0644(05)80195-7","volume":"22","author":"SA Stern","year":"1993","unstructured":"Stern SA, Dronen SC, Birrer P, Wang X (1993) Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 22:155\u2013163","journal-title":"Ann Emerg Med"},{"key":"441_CR38","unstructured":"Institute of Medicine Committee on Fluid Resuscitation for Combat Casualties (1999) Protocols of care at the cite of injury. D. N. A. P., Washington, pp 97\u2013108"},{"key":"441_CR39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-5728(01)00337-X","volume":"118","author":"SD House","year":"2001","unstructured":"House SD, Mao X, Wu G, Espinelli D, Li WX, Chang SL (2001) Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic\u2013pituitary\u2013adrenal axis. J Neuroimmunol 118:277\u2013285","journal-title":"J Neuroimmunol"},{"key":"441_CR40","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.4049\/jimmunol.168.8.4025","volume":"168","author":"PC Singhal","year":"2002","unstructured":"Singhal PC, Bhaskaran M, Patel J, Patel K, Kasinath BS, Duraisamy S, Franki N, Reddy K, Kapasi AA (2002) Role of p38 mitogen-activated protein kinase phosphorylation and Fas\u2013Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 168:4025\u20134033","journal-title":"J Immunol"},{"key":"441_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/089277902320913314","volume":"16","author":"AA Malik","year":"2002","unstructured":"Malik AA, Radhakrishnan N, Reddy K, Smith AD, Singhal PC (2002) Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection. J Endourol 16:605\u2013610","journal-title":"J Endourol"},{"key":"441_CR42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20052362","volume":"203","author":"JM Huston","year":"2006","unstructured":"Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623\u20131628","journal-title":"J Exp Med"},{"key":"441_CR43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/jpet.104.079707","volume":"312","author":"Y Han","year":"2005","unstructured":"Han Y, Englert JA, Yang R, Delude RL, Fink MP (2005) Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 312:1097\u20131105","journal-title":"J Pharmacol Exp Ther"},{"key":"441_CR44","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1073\/pnas.170226797","volume":"97","author":"L Liaudet","year":"2000","unstructured":"Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, Szabo C (2000) Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci U S A 97:10203\u201310208","journal-title":"Proc Natl Acad Sci U S A"},{"key":"441_CR45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jtcvs.2003.11.032","volume":"127","author":"YJ Woo","year":"2004","unstructured":"Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, Pirolli TJ, Berry MF, Hsu V, Grand T (2004) Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg 127:1262\u20131269","journal-title":"J Thorac Cardiovasc Surg"},{"key":"441_CR46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141\u2013179","journal-title":"Annu Rev Immunol"},{"key":"441_CR47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725\u2013734","journal-title":"Nat Rev Immunol"},{"key":"441_CR48","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","volume":"25","author":"MS Hayden","year":"2006","unstructured":"Hayden MS, West AP, Ghosh S (2006) NF-kappaB and the immune response. Oncogene 25:6758\u20136780","journal-title":"Oncogene"},{"key":"441_CR49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1084\/jem.189.11.1839","volume":"189","author":"ZW Li","year":"1999","unstructured":"Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839\u20131845","journal-title":"J Exp Med"},{"key":"441_CR50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.284.5412.321","volume":"284","author":"Q Li","year":"1999","unstructured":"Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321\u2013325","journal-title":"Science"},{"key":"441_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1074-7613(00)80042-4","volume":"10","author":"M Tanaka","year":"1999","unstructured":"Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV (1999) Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10:421\u2013429","journal-title":"Immunity"},{"key":"441_CR52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","volume":"376","author":"AA Beg","year":"1995","unstructured":"Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167\u2013170","journal-title":"Nature"},{"key":"441_CR53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20011885","volume":"195","author":"E Alcamo","year":"2002","unstructured":"Alcamo E, Hacohen N, Schulte LC, Rennert PD, Hynes RO, Baltimore D (2002) Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs. J Exp Med 195:233\u2013244","journal-title":"J Exp Med"},{"key":"441_CR54","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.96.6.2994","volume":"96","author":"TS Doi","year":"1999","unstructured":"Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y (1999) Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A 96:2994\u20132999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"441_CR55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.shk.0000188710.04777.9e","volume":"25","author":"LL Mantell","year":"2006","unstructured":"Mantell LL, Parrish WR, Ulloa L (2006) HMGB1 as a therapeutic target for infectious and inflammatory disorders. Shock 25:4\u201311","journal-title":"Shock"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0441-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-009-0441-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0441-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:20:21Z","timestamp":1684869621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-009-0441-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s00109-009-0441-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}